Menu
Personal finance
Burger King slims down for success
The Penguin-Random House merger: 3 takeaways
Dunkin' weathers storm to attract crowds
Inside Wall Street: Bank weathers its own storm
How Sandy will affect shipping business
The whopping US rally that wasn't
Disney acquires Lucasfilm for $4B
Late-inning earnings plays
Gilead's 'son of Viread' passes first test
Auto sales expected to stay strong into 2013
Why Yamana shares are soaring
Archer Daniels Midland is boring and cheap
Stericycle finds treasure in trash
Don't follow Icahn into Netflix
How to trade the US presidential election
David Einhorn is shorting iron ore
What's next for Exxon after Rosneft buy?
Who's right, Main Street or Wall Street?
Hershey shareholders sue for child labor records
China's growth picks up
Europe offsets Johnson Controls' Asia gains
CSX took too heavy a beating
In retail, pessimism doesn't pay
Illumina should reconsider Roche's offer
Stericycle finds treasure in trash
Can Stericycle (SRCL -0.76%) continue to turn trash into treasure for investors? That certainly appears to be the case. The suburban Chicago company specializing in treating and disposing of infectious medical waste hit a 52-week high last week.


The bump in share price came after Stericycle reported that revenue for the third quarter that ended Sept. 30, 2012, jumped more than 14% from the same period a year earlier. The company's gross profit was up a healthy 13.4%. But the lingering question is how to trade it. For our real time trading reports that help investors figure out exactly how to trade stocks like this, click here.



Stericycle continues to flex its muscles in an industry the company says was worth $15 billion worldwide in 2011. Unless some big solid waste players such as Waste Management (WM -1.44%) or Republic Services (RG) decide to re-enter a market they abandoned years ago, Stericycle appears poised to remain a man among boys for the foreseeable future.



Moreover, the company is ideally positioned to take advantage of projected industry growth. That's going to be driven by an aging population requiring more medical services, health care cost pressures, tougher environmental regulations, medical waste treatment moving outside hospitals and expansion outside the U.S.



Even with its dominant position in medical waste, Stericycle has plenty of upside. After all, the company owns just 13% of the worldwide market. The rest belongs to onsite management systems and other competitors, many of the latter being local or regional companies. Acquisitions have played a major role in Stericycle's growth, and the company began expanding outside the U.S. in 1998. It has a foothold in Japan, Argentina, Mexico, Canada and the United Kingdom, among others.



One company competing in Stericycle's space is Sharps Compliance (SMED 0.00%). Calling Sharps a competitor, however, might be somewhat of a stretch. The company, which specializes in collecting sharps such as needles and syringes, hasn't exactly wowed investors. Analysts project Sharps will lose 8 cents a share in its current fiscal year ending in June 2013 before returning to modest profitability the following year. Little wonder that the company trades at just above $3 a share, about the middle of its 52-week range.



Investors might be concerned that Stericycle is a bit pricey. After all, it sells at a lofty price-to-earnings ratio of 31 based on trailing earnings. That's almost twice as high as solid waste behemoths Waste Management and Republic Services. Then again, the margins in medical waste are much fatter.



Just how much upside does Stericycle hold for investors? Analysts estimate Stericycle will earn $3.28 per share in 2012 and $3.66 in 2013. If the company's price-to-earnings ratio holds, there may be another $10 to $20 of headroom.


For more information about stocks in this space, our real time trading reports help investors identify opportunities before they happen.

Для печати
Microsoft will 'die and disappear' in next few years
Whole Foods' freshness starting to wilt
In a war of attrition, Microsoft will beat Apple again
Asbury Automotive sees strong earnings momentum
Student debtors get the runaround
What to keep in your money survival kit
First-date coupon use is on the rise
Groupon offers NYC dinner in the dark
The worst credit cards of 2012
Post-Sandy, banks waive fees
Homeowners spared costly hurricane deductible
7 ways to commit financial suicide
Why are car loans so easy to get?
Best credit cards after bankruptcy
Get more cash for your old clothes
5 fee-free ways to help Sandy victims
After a flood, frugality can be dangerous
After the storm: Rebuild or move?
My unexpected $2,400 vet bill
Best credit cards for holiday shopping
Downside of a higher retirement age
Prepaid cards are not gift cards
Is the economy destroying love?
Financial lesson from a football game
Book Christmas flights before Black Friday
6 ways to earn extra holiday cash
Holiday shopping? Avoid this retail trick
Many holding out for Cyber Monday
SiriusXM drives straight race to $3 a share
Sandy: Beware the bubble in storm stocks
Starbucks: Buy it, own it, love it
4 Canadian value stocks
What's the White House worth?
Stocks are immune to Washington
EMC strengthens RSA business with acquisition
Russia garners another favorable valuation call
Goldman Sachs slashes partnership ranks
Inside Wall Street: Cheers from Bud and Diageo
4 favorites for a housing rebound
Is Baidu's China reign over?
In 2013, Apple, Facebook will fly, Intel will die
Is AOL's turnaround for real?
Stock buyback blitz continues
Anheuser-Busch pushes higher-alcohol beers
Baidu: Searching for growth in China
Twitter vs. Facebook: The war heats up
Would Disney buy Hasbro?
Vending-machine pizza prepares for US debut
Amazon lockers coming to Staples
Are customers becoming less loyal to Apple?
Focus on earnings, not fiscal cliff
Evergreen stocks: 4 favorite dividend ideas